These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 29557988)

  • 1. Personalized botulinum toxin type A therapy for cervical dystonia based on kinematic guidance.
    Samotus O; Lee J; Jog M
    J Neurol; 2018 Jun; 265(6):1269-1278. PubMed ID: 29557988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensorimotor Perceptive Rehabilitation Integrated (SPRInt) program: exercises with augmented movement feedback associated to botulinum neurotoxin in idiopathic cervical dystonia-an observational study.
    Castagna A; Caronni A; Crippa A; Sciumè L; Giacobbi G; Corrini C; Montesano A; Ramella M
    Neurol Sci; 2020 Jan; 41(1):131-138. PubMed ID: 31478151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical utility of botulinum toxin injections targeted at the motor endplate zone in cervical dystonia.
    Delnooz CC; Veugen LC; Pasman JW; Lapatki BG; van Dijk JP; van de Warrenburg BP
    Eur J Neurol; 2014 Dec; 21(12):1486-e98. PubMed ID: 25060697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin type B for cervical dystonia.
    Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of the efficacy of botulinum neurotoxin type a in treating cervical dystonia.
    Zhou X; Li ZF; Guo XZ; Wei Q; Niu YN; Li M; Xia JN; Chen LP
    Technol Health Care; 2024; 32(4):2421-2430. PubMed ID: 38073352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia.
    Brashear A; Lew MF; Dykstra DD; Comella CL; Factor SA; Rodnitzky RL; Trosch R; Singer C; Brin MF; Murray JJ; Wallace JD; Willmer-Hulme A; Koller M
    Neurology; 1999 Oct; 53(7):1439-46. PubMed ID: 10534248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized study of botulinum toxin versus botulinum toxin plus physical therapy for treatment of cervical dystonia.
    Hu W; Rundle-Gonzalez V; Kulkarni SJ; Martinez-Ramirez D; Almeida L; Okun MS; Wagle Shukla A
    Parkinsonism Relat Disord; 2019 Jun; 63():195-198. PubMed ID: 30837195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term tremor therapy for Parkinson and essential tremor with sensor-guided botulinum toxin type A injections.
    Samotus O; Lee J; Jog M
    PLoS One; 2017; 12(6):e0178670. PubMed ID: 28586370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
    Pappert EJ; Germanson T;
    Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia.
    Brin MF; Lew MF; Adler CH; Comella CL; Factor SA; Jankovic J; O'Brien C; Murray JJ; Wallace JD; Willmer-Hulme A; Koller M
    Neurology; 1999 Oct; 53(7):1431-8. PubMed ID: 10534247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of repeated doses of botulinum toxin type B in type A resistant and responsive cervical dystonia.
    Factor SA; Molho ES; Evans S; Feustel PJ
    Mov Disord; 2005 Sep; 20(9):1152-60. PubMed ID: 15954134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin type B for cervical dystonia.
    Marques RE; Duarte GS; Rodrigues FB; Castelão M; Ferreira J; Sampaio C; Moore AP; Costa J
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD004315. PubMed ID: 27176573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of single-photon emission computed tomography aided botulinum toxin injection in cervical dystonia: A double-blind, randomized study.
    Teng F; Malam Djibo I; Chen S; Su J; Pan Y; Zhang X; Xu Y; Feng L; Pan L; Jin L
    Parkinsonism Relat Disord; 2021 Oct; 91():77-82. PubMed ID: 34537494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dystonia discomfort scale (DDS): a novel instrument to monitor the temporal profile of botulinum toxin therapy in cervical dystonia.
    Dressler D; Kupsch A; Seitzinger A; Paus S
    Eur J Neurol; 2014 Mar; 21(3):459-62. PubMed ID: 24433495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Ability Improved in Essential Tremor by IncobotulinumtoxinA Injections Using Kinematically Determined Biomechanical Patterns - A New Future.
    Samotus O; Rahimi F; Lee J; Jog M
    PLoS One; 2016; 11(4):e0153739. PubMed ID: 27101283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of selective peripheral denervation for botulinum-toxin resistant patients with cervical dystonia.
    Münchau A; Palmer JD; Dressler D; O'Sullivan JD; Tsang KL; Jahanshahi M; Quinn NP; Lees AJ; Bhatia KP
    Brain; 2001 Apr; 124(Pt 4):769-83. PubMed ID: 11287376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of abobotulinumtoxinA liquid formulation in cervical dystonia: A randomized-controlled trial.
    Poewe W; Burbaud P; Castelnovo G; Jost WH; Ceballos-Baumann AO; Banach M; Potulska-Chromik A; Ferreira JJ; Bihari K; Ehler E; Bares M; Dzyak LA; Belova AN; Pham E; Liu WJ; Picaut P
    Mov Disord; 2016 Nov; 31(11):1649-1657. PubMed ID: 27653448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin type A and cervical dystonia: a seven-year follow-up.
    Camargo CH; Teive HA; Becker N; Munhoz RP; Werneck LC
    Arq Neuropsiquiatr; 2011 Oct; 69(5):745-50. PubMed ID: 22042174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum Toxin Type A Injections as Monotherapy for Upper Limb Essential Tremor Using Kinematics.
    Samotus O; Kumar N; Rizek P; Jog M
    Can J Neurol Sci; 2018 Jan; 45(1):11-22. PubMed ID: 29157315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia.
    Comella CL; Jankovic J; Shannon KM; Tsui J; Swenson M; Leurgans S; Fan W;
    Neurology; 2005 Nov; 65(9):1423-9. PubMed ID: 16275831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.